Innovator Intl Developed Power Buffer ETF

Innovator Intl Developed Power Buffer ETF

INOV
Innovator Intl Developed Power Buffer ETFUS flagNew York Stock Exchange Arca
33.99
USD
-0.23
(-0.16%)
1.87EPS
18.28P/E
11.81MMarket Cap
Innovator Intl Developed Power Buffer ETF
INOV
(New York Stock Exchange Arca)

Recent

price

33.99

P/E

ratio

18.28

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
This fund allocates a substantial portion of its net assets, typically at least 80%, to FLexible EXchange® Options tied to the iShares MSCI EAFE ETF. FLEX Options are a type of exchange-traded contract, distinguished by their customizable terms. The investment approach is structured to deliver specific results linked to the underlying ETF’s share price performance across a predetermined outcome period. This strategy aims to provide a buffer against the initial 15% of losses while capping potential upside gains over that annual period. The fund operates as a non-diversified investment vehicle.

Company News

APIChat
  • Inovalon's Real-World Data and Analytics Fuel Forbes' Inaugural Top Hospitals List & Ratings

  • Inovalon's Empower 2025 Showcases the Next Chapter in Data-Driven Healthcare

  • Inovalon's Data Solutions Group Wins BioTech Breakthrough Award for Best Analytics Solution Provider of the Year

  • Inovalon Celebrates Visionaries' Transformative Achievements in Healthcare With 2025 Impact Awards

  • Inovalon Unveils New Capabilities Across the Healthcare Continuum to Drive Smarter, More Connected Care and Operations

  • Inovalon Powers 70% of Medicare Advantage Enrollees in 4+ Star Plans, Continuing to Outperform National Averages in 2026 CMS Star Ratings

  • Inovalon Collaborates With DoseMe to Bring Precision Dosing Into Pharmacy Surveillance Workflows

  • Inovalon's Annual Empower Summit Set to Advance Data-Driven Healthcare

  • Inovalon Launches New Data and Analytics Offering on Snowflake AI Data Cloud for Healthcare & Life Sciences

  • Inovalon's Converged Quality Achieves 25th Consecutive NCQA HEDIS® Measure Certification

  • Inovalon RADV Audit Readiness Solution Earns Top Ranking From Black Book

  • Nominations Now Open For 2025 Inovalon Impact Awards Honoring Healthcare Excellence

  • Ed Chidsey Appointed President of Inovalon's Insights Business Unit

  • Karly Rowe Appointed as President of Inovalon's Provider Business Unit

  • Former Inovalon Exec, Michael Hasbany, Joins Healthmine

  • Inovalon Adds Safety Management to the PointClickCare Marketplace

  • Inovalon's Pharmacy Surveillance Software Achieves Best in KLAS For Eight Years in a Row

  • Inovalon Announces CEO Transition

  • Alterwood Advantage Selects Inovalon's Converged Solution Suite to Drive Superior Quality Measurement and Risk Adjustment Accuracy

  • Inovalon Recognizes Innovators Driving Healthcare Excellence with the 2024 Impact Awards